09.12.23
Dylan Carson’s extensive trial and courtroom experience in public and private antitrust enforcement further strengthens Manatt’s national antitrust practice
09.08.23
Thirteen Manatt attorneys were named to Lawdragon’s 2024 list of the 500 Leading Litigators in America, which recognizes the trial attorneys who represent some of the most powerful entities in the country and have achieved impressive victories in the courtroom.
09.05.23
A Manatt team that included Manatt Financial Services Partner Andrew Morrison, Litigation Partner Samantha Katze and Litigation Associate Tina Lapsia successfully represented Mullen Automotive Inc. (Mullen).
09.01.23
Joan Lukey was named to Lawdragon’s Hall of Fame – Litigators list, which recognizes the most highly respected trial attorneys for their career-long contributions to the legal industry.
Nine of Manatt’s professionals were named to various 2023 Law360 Editorial Boards, which provide insight on important legal issues to the publication’s team of reporters and editors.
08.29.23
Bezalel Stern was quoted in The National Law Journalwhere he discussed the Federal Trade Commission’s (FTC) recent scrutiny of companies’ claims about their use of artificial intelligence (AI) and what it means for market participants moving forward.
08.17.23
Best Lawyers named five Manatt attorneys “Lawyer of the Year” for 2024 – Marty Murphy in Boston; Edward Burg, Timi Anyon Hallem and George Kieffer in Los Angeles; and Susan Hori in Orange County.
Thirteen Manatt professionals were named to Best Lawyers in America’s 2024 “Ones to Watch” list, which recognizes attorneys that have been practicing for 5-9 years and have achieved outstanding professional excellence in private practice.
Eighty-two Manatt attorneys have been named to the 2024 edition of Best Lawyers in America, which recognizes the nation’s leading lawyers each year based on a nationwide peer-review survey.
08.14.23
Deborah Bachrach and Ronald Blum were quoted in Bloomberg Law on the various abortion restriction regulations stemming from the Dobbs decision, and how the lingering effects continue to impact medical treatment across the country.
